pitavastatin and Pulmonary-Arterial-Hypertension

pitavastatin has been researched along with Pulmonary-Arterial-Hypertension* in 1 studies

Reviews

1 review(s) available for pitavastatin and Pulmonary-Arterial-Hypertension

Article	Year
Current Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension. International journal of molecular sciences, 2019, Nov-23, Volume: 20, Issue:23 There are three critical pathways for the pathogenesis and progression of pulmonary arterial hypertension (PAH): the prostacyclin (prostaglandin I Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Delivery Systems; Humans; Imatinib Mesylate; Nanoparticles; Pulmonary Arterial Hypertension; Quinolines	2019

Article

Year

Current Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension.

International journal of molecular sciences, 2019, Nov-23, Volume: 20, Issue:23

There are three critical pathways for the pathogenesis and progression of pulmonary arterial hypertension (PAH): the prostacyclin (prostaglandin I

Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Delivery Systems; Humans; Imatinib Mesylate; Nanoparticles; Pulmonary Arterial Hypertension; Quinolines

2019